Outlook Therapeutics

Displaying resources from all locations.

Use the fields below to filter resources for a particular country, city, or state. Start by selecting the top most region, the other fields will be automatically updated to show available locations.

Use the Clear Filter button if you want to start over.

Outlook Therapeutics
Listing Title
Listing Category
Description

Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet age-related macular degeneration (wet AMD),...

Phone
609-619-3990
Address
485 Route 1 South, Building F, Suite 320
Iselin